Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Dr. Reddy s Laboratories Limited
Eligibility
Inclusion criteria
Inclusion criteria: Data records of 1.Adults 18 to 60 years 2.Diagnosed with androgenetic alopecia (male pattern) 3.Prescribed topical minoxidil 4.At least one documented follow-up visit after initiation of treatment
Exclusion criteria
Exclusion criteria: 1 Non-androgenetic alopecia hair/scalp disorders (alopecia areata, telogen effluvium, cicatricial alopecia, etc.) 2.Primarily treated with oral minoxidil (to isolate topical effects) 3.Insufficient documentation related to regimen duration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of clinical improvement in androgenetic alopecia following topical minoxidil therapy, based on physician-documented improvement in hair density or hair growth recorded in medical records, along with incidence of adverse events and treatment persistence/switching patterns from baseline through available follow-up visits up to 6 months.Timepoint: These outcomes will be assessed from baseline (initiation of topical minoxidil therapy) through all available follow-up visits up to 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes include assessment of the median time to first documented clinical improvement, proportion of patients discontinuing treatment due to adverse events, use of concomitant therapies alongside topical minoxidil (such as finasteride, dutasteride, PRP, microneedling, & hair transplantation), & comparison of clinical outcomes between different concentrations of topical minoxidil (5 percentage & 10 percentage).Timepoint: These outcomes will also be evaluated from baseline through the available follow-up period up to 6 months. | — |
Countries
India
Contacts
Public ContactDr B S Chandrashekar
CUTIS Academy of Cutaneous Sciences
Outcome results
None listed